US 8877795 — Patent Expiration

IDENTIFICATION OF STABILIZERS OF MULTIMERIC PROTEINS

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US8877795

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 8877795

Identification Of Stabilizers Of Multimeric Proteins

High Confidence

Application No. 13696505

May 5, 2031

4y 320d remaining

Earliest effective filing

May 5, 2011

+ 20 years

May 5, 2031

PTA +0d

May 5, 2031

TD cap (US 9642838)

Mar 14, 2033

Final

May 5, 2031

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Note: terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation Details

Base Term Calculation

Filing Date

January 23, 2013

Earliest Effective Filing

May 5, 2011

Issue Date

November 4, 2014

PTA

0 days

Base Expiry (before PTA)

May 5, 2031

May 5, 2011 + 20 years = May 5, 2031

National Stage Entry of application PCTUS2011035350, filed May 5, 2011

PRO

61332638 — Provisional — not used for base term

PRO

61332638 — Provisional — not used for base term

Terminal Disclaimer Analysis

TD Approved

2 approved, 2 filed

TD caps expiration to March 14, 2033 (earliest expiring referenced patent: US 9642838)

US 13696505

Could not resolve calculation details

US 9642838(App. 14876447)

Capping Patent

Compounds And Compositions That Bind And Stabilize Transthyretin And Their Use For Inhibiting Transthyretin Amyloidosis And Protein-protein Interactions

Filing Date

Oct 6, 2015

Earliest Effective Filing

Mar 14, 2013

Issue Date

May 9, 2017

PTA

0 days

Calculated Expiration

Mar 14, 2033

Continuation of 13830731, filed Mar 14, 2013, issued as US 9169214

Mar 14, 2013 + 20y = Mar 14, 2033

US 9913826(App. 15480139)

Compounds And Compositions That Bind And Stabilize Transthyretin And Their Use For Inhibiting Transthyretin Amyloidosis And Protein-protein Interactions

Filing Date

Apr 5, 2017

Earliest Effective Filing

Mar 14, 2013

Issue Date

Mar 13, 2018

PTA

0 days

Calculated Expiration

Mar 14, 2033

Continuation of 14876447, filed Oct 6, 2015, issued as US 9642838

Continuation of 13830731, filed Mar 14, 2013, issued as US 9169214

Mar 14, 2013 + 20y = Mar 14, 2033

US 10398681(App. 15883750)

Compounds And Compositions That Bind And Stabilize Transthyretin And Their Use For Inhibiting Transthyretin Amyloidosis And Protein-protein Interactions

Filing Date

Jan 30, 2018

Earliest Effective Filing

Mar 14, 2013

Issue Date

Sep 3, 2019

PTA

0 days

Calculated Expiration

Mar 14, 2033

Continuation of 15480139, filed Apr 5, 2017, issued as US 9913826

Continuation of 14876447, filed Oct 6, 2015, issued as US 9642838

Continuation of 13830731, filed Mar 14, 2013, issued as US 9169214

Continuation of 14876447, filed Oct 6, 2015, issued as US 9642838

Continuation of 13830731, filed Mar 14, 2013, issued as US 9169214

Mar 14, 2013 + 20y = Mar 14, 2033

US 10842777(App. 16510574)

Compounds And Compositions That Bind And Stabilize Transthyretin And Their Use For Inhibiting Transthyretin Amyloidosis And Protein-protein Interactions

Filing Date

Jul 12, 2019

Earliest Effective Filing

Mar 14, 2013

Issue Date

Nov 24, 2020

PTA

0 days

Calculated Expiration

Mar 14, 2033

Continuation of 15883750, filed Jan 30, 2018, issued as US 10398681